Morgan Stanley’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57K | Hold |
4,120
| – | – | ﹤0.01% | 7273 |
|
|
2025
Q1 | $3.93K | Sell |
4,120
-2,000
| -33% | -$1.91K | ﹤0.01% | 7043 |
|
|
2024
Q4 | $11.1K | Hold |
6,120
| – | – | ﹤0.01% | 6765 |
|
|
2024
Q3 | $8.81K | Sell |
6,120
-11,806
| -66% | -$17K | ﹤0.01% | 6758 |
|
|
2024
Q2 | $22.9K | Buy |
17,926
+12,305
| +219% | +$15.8K | ﹤0.01% | 6413 |
|
|
2024
Q1 | $21.2K | Sell |
5,621
-3,915
| -41% | -$14.8K | ﹤0.01% | 6467 |
|
|
2023
Q4 | $49.1K | Buy |
9,536
+9,035
| +1,803% | +$46.5K | ﹤0.01% | 6390 |
|
|
2023
Q3 | $2.45K | Sell |
501
-256
| -34% | -$1.25K | ﹤0.01% | 7087 |
|
|
2023
Q2 | $4.44K | Buy |
+757
| New | +$4.44K | ﹤0.01% | 7013 |
|
|
2023
Q1 | – | Sell |
-12
| Closed | -$51 | – | 7814 |
|
|
2022
Q4 | $51 | Buy |
+12
| New | +$51 | ﹤0.01% | 7732 |
|